环孢菌素 D结构式
|
常用名 | 环孢菌素 D | 英文名 | Val2-Cyclosporine |
---|---|---|---|---|
CAS号 | 63775-96-2 | 分子量 | 1216.638 | |
密度 | 1.0±0.1 g/cm3 | 沸点 | 1294.7±65.0 °C at 760 mmHg | |
分子式 | C63H113N11O12 | 熔点 | 148-151ºC | |
MSDS | N/A | 闪点 | 736.8±34.3 °C | |
符号 |
GHS02, GHS07 |
信号词 | Danger |
环孢菌素 D用途Cyclosporin D 是 Cyclosporin A 的代谢产物,是一种弱免疫抑制剂。Cyclosporin D 作为 Cyclosporin A 定量的内标,Cyclosporin A 是一种免疫抑制药物,通过抑制钙调磷酸酶和钙调磷酸酶依赖性转录因子激活的T细胞核因子 (NFAc) 来抑制 T 细胞活化。 |
中文名 | 环孢菌素 D |
---|---|
英文名 | Cyclosporin D |
中文别名 | 环[L-丙氨酰-D-丙氨酰-N-甲基-L-亮氨酰-N-甲基-L-亮氨酰-N-甲基-L-缬氨酰-3-羟基-N,4-二甲基-L-2-氨基-6-辛烯酰-L-缬氨酰-N-甲基甘氨酰-N-甲基-L-亮氨酰-L-缬氨酰-N-甲基-L-亮氨酰] | 环孢霉素D |
英文别名 | 更多 |
描述 | Cyclosporin D 是 Cyclosporin A 的代谢产物,是一种弱免疫抑制剂。Cyclosporin D 作为 Cyclosporin A 定量的内标,Cyclosporin A 是一种免疫抑制药物,通过抑制钙调磷酸酶和钙调磷酸酶依赖性转录因子激活的T细胞核因子 (NFAc) 来抑制 T 细胞活化。 |
---|---|
相关类别 | |
体外研究 | 环孢素D体外抑制钙/钙调素依赖的EF-2磷酸化[1]。 |
体内研究 | 环孢素D是佛波酯TPA诱导小鼠皮肤生物效应的体内有效抑制剂[1]。 |
参考文献 |
密度 | 1.0±0.1 g/cm3 |
---|---|
沸点 | 1294.7±65.0 °C at 760 mmHg |
熔点 | 148-151ºC |
分子式 | C63H113N11O12 |
分子量 | 1216.638 |
闪点 | 736.8±34.3 °C |
精确质量 | 1215.857056 |
PSA | 275.64000 |
LogP | 3.70 |
外观性状 | 无色至灰白色结晶固体 |
蒸汽压 | 0.0±0.6 mmHg at 25°C |
折射率 | 1.468 |
储存条件 | 20°C |
符号 |
GHS02, GHS07 |
---|---|
信号词 | Danger |
危害声明 | H225-H302 + H312 + H332-H319 |
警示性声明 | P210-P280-P305 + P351 + P338 |
危害码 (欧洲) | F,Xn,T |
风险声明 (欧洲) | 11-20/21/22-36-39/23/24/25-23/24/25 |
安全声明 (欧洲) | 16-36/37-45-7 |
危险品运输编码 | UN 1648 3 / PGII |
海关编码 | 29419090 |
Antimalarial activity of cyclosporins A, C and D.
Afr. J. Med. Med. Sci. 23(1) , 47-51, (1994) Cyclosporin A (CsA) is an immunosuppressive drug widely used in organ transplants. It is also accumulated by the erythrocyte, a site that accommodates one of the stages of malaria parasite. We observe... |
|
Enzymatic synthesis of cyclosporin A.
J. Biol. Chem. 262(36) , 17258-9, (1987) An enzyme fraction, isolated from crude extracts of the fungus Tolypocladium inflatum, strain 7939/F, is able to synthesize the undecapeptide cyclosporin A. The formation of cyclosporin A was monitore... |
|
In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.
Immunopharmacol. Immunotoxicol. 15(2-3) , 163-77, (1993) Cyclosporine A (CsA) and its major metabolites: M1, M17 and M21 and two analogues: cyclosporines C (CsC) and D (CsD), were studied for their capacity to interfere with different in vitro activation pa... |
33-[(4E)-1-Hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
CyclosporinD |
cyclosporine D |
Val2-Cyclosporine |
1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone, 33-[(4E)-1-hydroxy-2-methyl-4-hexen-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-3,21,30-tris(1-methylethyl)-6,9,18,24-tetrakis(2-methylpropyl)- |
33-[(4E)-1-Hydroxy-2-methyl-4-hexen-1-yl]-6,9,18,24-tetraisobutyl-3,21,30-triisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone |
7-L-Valinecyclosporin A |
Cyclosporin Impurity 4 |